This shows you the differences between two versions of the page.
Previous revision | |||
— | home:publications:albert_hmrc_2010 [07.04.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | |||
+ | ====== Poster - Multiple reports of symptom exacerbation on immunostimulatory treatment for autoimmune disease ====== | ||
+ | |||
+ | |||
+ | **Type:** Poster presentation\\ | ||
+ | **Presented by:** Paul Albert\\ | ||
+ | **Conference: | ||
+ | **Location: | ||
+ | **Date: | ||
+ | **Additional Content: | ||
+ | |||
+ | |||
+ | ===== Abstract ===== | ||
+ | |||
+ | |||
+ | Over the past seven years, we have been observing patients with autoimmune diagnoses use the VDR-agonist olmesartan to stimulate components of the innate immune response. Nearly all of the hundreds of patient reported outcomes describe an initial increase in symptoms specific to their autoimmune diagnoses. Additionally, | ||
+ | |||
+ | {{tag> | ||